Recently, CardioNerds correspondent Dr. Liane Arcinas spoke with Kamala Tamirisa, MD, FACC, FHRS, Cardiac Electrophysiology, Advanced Cardiac Imaging, Texas Cardiac Arrhythmia Institute, about two recent studies focused on women in underrepresented racial/ethnic groups and about the field of cardiac electrophysiology. Dr. Tamirisa spoke about, among other things, how to promote diversity in the cardiac space, and how to undo the implicit biases women often face in the field, specifically women who are ethnic minorities.
Also, check out a previous CardioNerds podcast which featured Dr. Tamirisa on the topic of Empowerment & Growing Together as Women in EP.
Dr. Liane Arcinas: Hello, everyone. Im Dr. Liane Arcinas, PGY6 Cardiology Fellow at the University of Manitoba, Canada, and soon-to-be Cardiac Electrophysiology Fellow. Im a proud cardio unit fellow-in-training trialist and medical journalism correspondent for DocWire News in collaboration with CardioNerds.
Dr. Liane Arcinas: Its my great pleasure to introduce Dr. Kamala Tamirisa, a Clinical Cardiac Electrophysiologist at Texas Cardiac Arrhythmia, Co-chair for American College of Cardiology, Women in Cardiology Advocacy Work Group, and National ACC Women in Cardiology Leadership Council member. Today, we will be talking about two studies recently published in Heart Rhythm and JET EP on women in underrepresented racial and ethnic groups and cardiac electrophysiology.
Dr. Liane Arcinas: But before we dive into these studies, I would like to welcome Dr. Tamirisa first. Dr. Tamirisa, I am so excited to talk to you today. Can you tell us a little bit more about yourself and why you chose a career in cardiac electrophysiology?
Dr. Kamala Tamirisa: Thank you for having me, Liane. This is an absolute pleasure to talk to a mentee and someone who is going to be another woman in EP. Ill answer a question, just your first question. I am a clinical electrophysiologist and Ive been doing EP for about 14 years now. I recently moved to Texas and Im with Texas Cardiac Arrhythmia Institute.
Dr. Kamala Tamirisa: Another exciting thing is I am the chair for the HRS DNI Council, and its an honor to play that role. I love EP. I decided on doing EP, lets see, probably end of my medical school or internship. EKGs are my passion. Anyone who knows me, I love EKGs and anything to do with EKGs and EP. Thats the driving force behind why I chose EP.
Dr. Liane Arcinas: Well, EP truly is a very gratifying and exciting field, and it sounds like you really truly enjoy the job, which is great. Its so nice to have a mentor like you. Dr. Tamirisa, I would like to know more about your feedback on two recent studies presented at heart rhythm this year. The first one is by Dr. Howell and her colleagues.
Dr. Liane Arcinas: They found that only about 5% of moderate volume EP operators in the United States are women, and this is despite the increase in the number of female trainees and ablationists over the last few years. Although an estimated 12% of EP trainees are women, there are only 5% moderate volume EP operators, pointing to possible attrition or preference of female training needs to do only clinical EP after training, instead of also doing procedures.
Dr. Liane Arcinas: Can you think of reasons why this may be, and what can we do to help improve not only the number of female EPS, but also the number of female EP procedure lists?
Dr. Kamala Tamirisa: Thats a great question and a few plausible reasons come to my mind. Ill start off dividing these into categories. One is issue of a plugged pathway. As you know, for the ACGME report, even though the number of total EP trainees increased between 2013 and 2019 by 75%, that is 146 to 255 only EP trainees, the number of women EP trainees increased only from 17 to 28. I want our audience to know this, that we just increased from 17 to 28, with the percentage of women EP trainees actually decreasing from 12% in 2013 to 9% in 2019 to 2020.
Dr. Kamala Tamirisa: Now, you asked me, what would be the possible reasons? Ill just jump on and talk about some solutions, because I think we have enough data, Liane. We need to start talking about solutions. Lets talk about solution. I think the early exposure to the field is super important. How do you expose people to EP? Start off with electives in medical school, start off with training people and bringing them into the EP lab. I think each program director, each training program, we need to do that. Listening to the stories of Women in EP.
Dr. Kamala Tamirisa: How do they live outside the lab? How do they manage their life outside the lab is also important for other women who want to pursue the field. And then, how can we have more exposure to the role models? How about we organize some regional meetings through HRS or any other organization? Regional meetings where more medical students and even the interns can submit abstracts, they get to interact with the role models of Women in EP. And then I want the audience to know there are mentor-mentee programs, including the ACC one, and also the Women as One is an incredible organization where they can have an access to the mentors.
Dr. Kamala Tamirisa: Moving on to the second solution, its the issue of the leaky pathway. As you know, theres several causes; pay inequity, gender inequity with regards to pay, and poorly defined paternal and maternal leaves, parental leaves, and then environment and the culture. This is not something that you and I are just its not an opinion-based thing. We know from the JET paper, these were looked at, and these were actual facts. And what are the solutions? Solutions are women are not very good negotiators when it comes to their own contract. We negotiate on behalf of everyone else, but we are not super good at about negotiating what we want, how to customize our own lives and our careers. Thats number one.
Dr. Kamala Tamirisa: Then having standardized policies for parental leave is important. Another important thing is women as leaders, or even as coming into the field, I think we need to be sitting in the boardroom at the table. For us to change policies or talk about it, lets meet and participate in a dialogue. Then for the organizations, whether at an institutional level or at HRS or ACC, as you know, incredible job has been done with regards to zero tolerance for sexual harassment or any kind of harassment, and protecting women from repercussions. If they go and complain against someone, there should not be repercussions, and we need to protect them. Then lets engage our male allies. I think thats another key important part of the solution. Then training and support for younger generation women into leadership.
Dr. Kamala Tamirisa: The last point Ill touch on are the barriers and the misconceptions. As you know, we already talked about the barriers. Mind you, there are also misconceptions. People still think that A-fib ablation, for example, is a five to six-hour procedure. Its not. Its much shorter. Then radiation, as you know, is another barrier that we worry about. The truth of the matter is for the younger generations like yourself, I think the zero-fluoroscopy procedures using 3D mapping, intracardiac echo, its an exciting part of the field. The radiation risk is going down and its much better than when I trained several years ago. The procedure times are not as long.
Dr. Kamala Tamirisa: The last point is the lactation facilities and the pregnancy flexibility. Its a work in progress, but we are in much better shape than we were several years ago.
Dr. Liane Arcinas: Well, thank you for that very insightful feedback and for laying out very detailed solutions. Thats amazing. In another study by Dr. Batnyam and her colleagues, they found that women only comprised 13 to 15% of clinical cardiac EP fellowship applicants.
Dr. Liane Arcinas: Moreover, there was an even smaller number of applicants who self-identified with underrepresented racial and ethnic groups last year, with only 3% Black or African Americans, 5% Hispanic, Latino or Spanish origin, and no applicants at all identifying as American Indian, Alaska Native, Native Hawaiian, or Pacific Islander. Why do you think this is the case, and how can we promote increased diversity in fellowship training?
Dr. Kamala Tamirisa: Again, another great question. Just adding onto the above factors, Liane, lack of role models. We were just talking about paucity of Women in EP leadership or EP operators in the previous article. Now, if you have low number of role models, obviously we will have lower number of people who are interested in the field. Starting again, in high school and premed, and even medical school or internship year. Start early.
Dr. Kamala Tamirisa: Something I commonly use; see me, be me. The more you see people like me, the more people are going to do this. Then making the environment more inclusive. How can we do that on the individual level, organization levels? I think its commonsense and kindness. Be an ally. If you see something where the environment is not amenable for adequate and optimal growth, call it out. Be an ally, be a self-advocate, and be an up-stander for others, and that is super important.
Dr. Kamala Tamirisa: Then also, start off with undoing the implicit bias. Just recently, Ill tell you, a patient asked me, Oh, you are a woman? You are a surgeon? You do procedures? I said, Yes, I am a woman. There are a bunch of implicit biases out there within us, within our patients, and as an organization. Making a conscious and a constant effort to undo those implicit biases are important. Then encourage each other, cause a ripple effect, and we will get there.
Dr. Kamala Tamirisa: Last thing is the mentors. Having mentors and sponsors is so important, and then reach out to mentors and sponsors. How can we at this level be good sponsors? Always invite others to write papers. If a male is invited and if he is too busy, I ask our male allies, Please invite women trainees to come in and say, Hey, do you want to write a paper with me? Or just call, help us out and make space for us to grow. Because truly, I think we have a great potential and we are making good strides, but we have long ways to go.
Dr. Liane Arcinas: Thank you. Can you please talk about the HRS Leadership and DEI Council roadmap, and the actionable steps that the council is planning to help promote increased diversity, equity and inclusion in cardiac electrophysiology?
Dr. Kamala Tamirisa: Absolutely. As the current chair of HRS DEI Council, under the guidance of the HRS Leadership and the Board of Trustees, we recently developed a strategic roadmap to achieve our goal to increase representation of underrepresented faculty, including women at HRS sponsored events to at least 25% by May of 2026. Thats our midterm goal. We as a team and our organization have also developed several short term goals to create DE&I standards for events and panels supported by HRS, using collected data to diversify our activities and capitalizing on the GLOW Program, which is already there for early career women EPS.
Dr. Kamala Tamirisa: We are currently working on another exciting program under the council, called the GLOBE Program. The GLOBE is for the Black electrophysiologists, to increase and diversify our field. Maybe you heard about this, HRS TV is another entity within the organization which is working with us, looking at Women in EP Mentorship Series. I have done several interviews. Again, promoting the role models, promoting the mentors and the sponsors, people who have done excellent work. Lastly, the HRS Presidents and our CEO, Pat Blake, are passionate about diversifying our world and inclusion, and its the fabric of this passion is inclusion. Ultimately, why do all this, Liane? Why do we talk about all this? Ultimately, its to benefit our patients.
Dr. Liane Arcinas: Yes. It sounds like theres many amazing initiatives that are coming on the road ahead, and Im really looking forward to how it would improve diversity in electrophysiology and improve patient care. That is so exciting.
Dr. Liane Arcinas: What message do you want to convey to our audience right now who may be thinking of pursuing a career in cardiac electrophysiology, and how about to those who are already practicing electrophysiologists?
Dr. Kamala Tamirisa: Well, EP is an exciting field, cutting edge technology, the deductive logic, innovation, and its a beautiful field for the future young mentees like yourself, and trainees like yourself. Integration of AI, precision medicine, theres so much to look forward to, and so I just hope a lot of women come and join our field. The flexibility and subspecialty advantages are there, Liane.
Dr. Kamala Tamirisa: This is something I tell people, Once you become an EP physician, as a woman in EP, you can negotiate your hours. I do lab days and clinic days, and they do translate into excellent or very good quality of life. Work-life integration is a work in progress and its something that needs to be customized. That is absolutely, can be done in EP. The last thing, we dont get up in the night to do STEMI calls. Our calls are much easier.
Dr. Kamala Tamirisa: Women in EP is a wonderful core group. We are very close. We lift each other. Then reach out to all the mentors, get guidance. For those women who are in EP and who are wonderful leaders, thank you to everything that they do. My mentors and my sponsors, like Dr. Russo, Dr. Alkajib and Dr. Hurwitz and many more, theyre incredible leaders in the field. Im just grateful to be in the field and look forward to having many more women join our team.
Dr. Liane Arcinas: Well, thank you, Dr. Tamirisa. Im so grateful to be able to talk to you today. Thank you so much for talking about this very important topic.
Dr. Kamala Tamirisa: Thank you for having me and good luck with everything. Reach out to your mentors and sponsors.
Dr. Liane Arcinas: Thank you so much.
See the rest here:
CardioNerds: Dr. Kamala Tamirisa On the Importance of Representation in Cardiology - DocWire News
- Best 30 Cardiology in Secaucus, NJ with Reviews - YP.com [Last Updated On: April 12th, 2018] [Originally Added On: April 12th, 2018]
- Cardiology | Weill Cornell Medicine [Last Updated On: April 14th, 2018] [Originally Added On: April 14th, 2018]
- Cardiology Conferences 2018 | Cardiology Meetings 2018 ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Dr. Anil Goel, MD - Birmingham, MI - Cardiology & Clinical ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Clinical Physiology (Cardiology) MSc/PGDip | Middlesex ... [Last Updated On: May 15th, 2018] [Originally Added On: May 15th, 2018]
- Cardiology Conferences 2018 | Upcoming Cardiology ... [Last Updated On: May 16th, 2018] [Originally Added On: May 16th, 2018]
- Clinical Cardiology Section | Cleveland Clinic [Last Updated On: May 27th, 2018] [Originally Added On: May 27th, 2018]
- Journal of Clinical and Experimental Cardiology - Open ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Cardiology Summit 2018 | Cardiology Conferences | Heart ... [Last Updated On: June 23rd, 2018] [Originally Added On: June 23rd, 2018]
- Cardiology Clinical and Research Faculty Members ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- Cardiology Conferences 2018 | Cardiology Congress 2018 ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- About Us - New Jersey Cardiology Associates [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- About Us - Ventura Clinical Trials [Last Updated On: August 16th, 2018] [Originally Added On: August 16th, 2018]
- Clinical Cardiology Made Ridiculously Simple: Michael A ... [Last Updated On: August 22nd, 2018] [Originally Added On: August 22nd, 2018]
- Clinical Cardiology - American Society of Preventive Cardiology [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Heart Surgery Hospital in india | Cardiology Treatment ... [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Clinical Cardiology - American Society of Preventive ... [Last Updated On: December 3rd, 2018] [Originally Added On: December 3rd, 2018]
- Guideline Clinical App - American College of Cardiology [Last Updated On: December 7th, 2018] [Originally Added On: December 7th, 2018]
- Journal of Clinical and Experimental Cardiology- Open ... [Last Updated On: December 12th, 2018] [Originally Added On: December 12th, 2018]
- Clinical Cardiology - Baptist Health [Last Updated On: December 30th, 2018] [Originally Added On: December 30th, 2018]
- Cardiology at Cancun: Topics in Clinical Cardiology [Last Updated On: February 5th, 2019] [Originally Added On: February 5th, 2019]
- Department of Cardiovascular Medicine, KU School of Medicine [Last Updated On: March 10th, 2019] [Originally Added On: March 10th, 2019]
- Towards Health Equality: Improving the Management of Cardiovascular Diseases in Women - International Atomic Energy Agency [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai - Yahoo Finance [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Will Renal Denervation for Hypertension Rise Again? - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Obstructive Sleep Apnea, Sleep Symptoms, and their Association with Cardiovascular Disease - DocWire News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- CNE expands pulmonary, sleep services with Brigham & Women's physicians - Warwick Beacon [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- What I Am Most Looking Forward to at TCT 2019 - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Sacubitril-Valsartan Not Linked to Lower Hospitalization Risk, CV Death in HFpEF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA clears multiuse angiography systems from Siemens Healthineers - DOTmed HealthCare Business News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- RWJBarnabas Health, St. Luke's University Health launch clinical affiliation - FierceHealthcare [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Bilirubin: A Novel Indicator of Infective Endocarditis Adverse Outcomes - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Community-based Care Model Reduces CVD Risk - Managed Healthcare Executive [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- American College of Cardiology Steps Up: Equal Pay, Opportunities for All - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form - AJMC.com Managed Markets Network [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy - Health Imaging [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- TCT 2019 Day Two: Transcatheter Valves, New and Old - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival - Diagnostic and Interventional Cardiology [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy... [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Off Script: The New Gatekeepers of Procedural Education - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE - BioSpace [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- The Heart of the Matter: Cardiovascular Fitness in Horses - United States Eventing Association [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Google parent Alphabet hires former FDA head Robert Califf to lead health strategy and policy - FierceHealthcare [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Inclisiran Benefits Patients With Familial Hypercholesterolemia and ASCVD - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy - Medscape [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis - Newswise [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Dapagliflozin Improves Heart Failure-Related Health Status in HFrEF - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Remote Ischemic Conditioning Did Not Improve 12 Month Clinical Outcomes After STEMI - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Insights from the European Society of Cardiology congress | Speaking of Medicine - PLoS Blogs [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Smokers Have More Pulmonary Emboli, Leading to Higher Hospital Readmission Rates | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- AZ's Farxiga gets heart failure prevention okay from FDA - PMLiVE [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The G | DMSO - Dove Medical Press [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis - PRNewswire [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Even With Same Diagnosis, Women Get Half the Heart Attack Treatments as Men - AJMC.com Managed Markets Network [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Eva Dickerman, Andrew Weil - The New York Times [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- EHR vendor Veradigm and partners creating new shared data tools for researchers - Healthcare IT News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy - DocWire News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deborah Heart and Lung Center announces affiliation with Cleveland Clinic Heart & Vascular Institute - Health Essentials from Cleveland Clinic [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- New Registry to Provide Insight into STEMI Occurrence, Treatment in North India | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Finding Your Best Fit in Cardiology - TCTMD [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Cardiology team expands to meet community need - The Union of Grass Valley [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deaths After Ablation of Atrial Fibrillation 'Concerning' in Real-World Analysis - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cutler Family gifts $15 million to University Hospitals to transform mens health care - Newswise [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Caregiving and the Soul of Medicine - Medscape [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical publishes positive results from the AMBULATE pivotal study Cardiology2.0 - Cardiology2.0 [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Gaps in Access to TAVR and SAVR: 'Something Needs to Be Done' - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical... [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential - 24/7 Wall St. [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,... [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]